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Abstract. We have screened a diverse array of iridium 
complexes derived from chiral N,P-ligands as catalysts for 
the asymmetric hydrogenation of vinylsilanes, a 
transformation for which generally applicable catalysts 
were lacking. Several catalysts emerged from this study 
that enabled highly enantioselective hydrogenation of a 
wide range of vinylsilanes with trisubstituted or 
disubstituted terminal C=C bonds bearing aryl, alkyl, 
carboethoxy, or hydroxymethyl substituents. In addition to 
trimethylsilyl and dimethyl(phenyl)silyl derivatives, 
trialkoxysilyl- and silacyclobutyl-substituted alkenes were 
used as substrates. 
Keywords: Asymmetric hydrogenation; Iridium; N,P-
ligands; Vinylsilanes 
 
Chiral organosilanes are synthetically valuable 
compounds, which have found use as versatile 
precursors for selective carbon–carbon bond 
formation1 or as chiral catalysts2 for asymmetric 
transformations. In addition, C-Si bonds can be 
converted into C-O bonds in a stereospecific manner 
by Fleming-Tamao oxidation.3 Furthermore, due to 
their low toxicity and favorable metabolic profiles, 
chiral organosilanes have received increasing 
attention in medicinal chemistry.4 Therefore, methods 
that enable the synthesis of highly enantioenriched 
chiral organosilicon compounds are of great interest. 
Several enantioselective routes to chiral 
organosilanes have been described, such as the 1,4-
addition of silicon nucleophiles to prochiral α,β-
unsaturated carbonyl compounds5 or the 1,4-addition 
of carbon6 or hydrogen7 nucleophiles to silyl-
substituted α,β-unsaturated carbonyl compounds 
leading to chiral β-silyl carbonyl compounds. 
Enantioenriched allylsilanes are conveniently 
accessible by copper-catalyzed enantioselective 
allylic substitution.8 The most general and widely 
used method for the synthesis of chiral silanes is the 
asymmetric hydrosilylation of alkenes, pioneered by 
Hayashi.9 High enantioselectivities were achieved 
with monosubstituted or 1,2-disubstituted alkenes, 
whereas 1,1-disubstituted alkenes usually react with 
lower enantioselectivity, especially those with 
terminal dialkyl-substituted C=C bonds. Moreover, 
regioselectivity is a frequently encountered problem. 
In this respect, asymmetric hydrogenation of 
vinylsilanes provides a potentially attractive 
alternative. However, examples of this approach to 
chiral silanes are scarce. In 2006, Andersson and 
coworkers reported the first enantioselective 
hydrogenation of vinylsilanes by iridium catalysts 
derived from chiral phosphino-thiazoline or 
phosphino-oxazoline ligands.10a However, only in one 
case, using (E)-trimethyl(2-phenylprop-1-en-1-
yl)silane as substrate (structure 7c in Table 1), high 
enantiomeric excesses of up to 98% were obtained, 
while other vinylsilanes reacted with moderate to 
poor enantioselectivities of 28-58% ee.  In 
subsequent studies additional Ir N,P-ligand 
complexes were tested, although solely in the 
hydrogenation of 7c.10b,c After completion of our 
work described herein, Li et al. reported a study on 
the asymmetric hydrogenation of vinylsilanes with an 
Ir-ThrePHOX catalyst (ligand 3b in Fig.1).10d They 
obtained high enantioselectivities in several cases but 
the range of substrates investigated was limited to 
vinylsilanes with a terminal C=C bond. Therefore, the 
availability of other catalysts that enhance the 
substrate scope of this transformation is clearly 
desirable. 
As part of our long-term studies of Ir-catalyzed 
asymmetric hydrogenation,11-24 we explored the 
potential of various classes of chiral Ir N,P-ligand 
complexes for the enantioselective hydrogenation of 
vinylsilanes. Ir complexes of this type have 
considerably enhanced the scope of asymmetric 
hydrogenation of olefins because they do not require 
the assistance of a coordinating group in vicinity of 
the C=C bond like Rh and Ru diphosphine complexes. 
The range of substrates that have been successfully 
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hydrogenated with these catalysts comprises a wide 
variety functionalized and unfunctionalized olefins.11, 
19-24 Even purely alkyl-substituted alkenes were found 
to react with excellent enantioselectivities and high 
turnover numbers. Therefore, we thought that alkenes 
bearing a silyl instead of an alkyl group should be 
feasible substrates as well. Here we report the results 
of a systematic hydrogenation study of a diverse 
range of vinylsilanes using Ir complexes derived from 
N,P-ligands 1-6 as catalysts (see Figure 1). 
 
Fig. 1 Chiral N,P-ligands used in this study. 
For our studies we selected representative 
examples of Ir catalysts derived from oxazoline-
based N,P-ligands PHOX,13 PyrPHOX,14 
ThreePHOX,15 and SimplePHOX,16 an imidazoline 
analog of SimplePHOX 5a,17 and a series of pyridine-
based N,P ligands 6a-d18 (Fig. 1), which we had 
successfully applied in previous studies. For an initial 
screening, we chose (E)-trimethyl(2-phenylbut-1-en-
1-yl)silane (7a) as substrate. Using 0.5 mol% catalyst 
under 50 bar of hydrogen gas, all catalysts tested 
gave full conversion to the saturated silane 8a within 
2h at room temperature (entries 1-7, Table 1). In 
general, complexes with phosphinite based N,P-
ligands gave higher enantioselectivities (86-98% ee) 
than PHOX  or PyrPHOX ligands (Table 1, entries 3-
7 vs entries 1-2). The best enantioselectivity (98% ee) 
was achieved with the bicyclic pyridine-phosphinite 
ligand 6b. 
In the hydrogenation of (E)-(2-cyclohexylbut-1-en-
1-yl)trimethylsilane  (7b) lacking an aromatic 
substituent, most catalysts that had given high 
enantioselectivities for 7a performed poorly (entries 
10-12), with the exception of complexes derived from 
pyridine-based ligands 6a and 6b (entries 13-14). The 
latter clearly performed best, affording the desired 
product 8b with full conversion and 96% ee. 
 
Table 1 Asymmetric hydrogenation of vinylsilanes with 
trisubstituted C=C bonds. 
 
Entry Substrate L 
Conv. 
(%)a 
Ee (%)b 
1 
 
(S)-1a >99 8 (-) 
2 (S)-2a >99 31 (-) 
3 (4S, 5S)-3a >99 94 (+) 
4 (S)-4a >99 87 (-) 
5 (R)-5a >99 86 (+) 
6 (S)-6a >99 91 (+) 
7 (R)-6b >99 98 (-) 
8 
 
(S)-1a 58 18 (-) 
9 (S)-2a 44 8 (-) 
10 (4S, 5S)-3a >99 28 (+) 
11 (S)-4a >99 50 (+) 
12 (R)-5a >99 20 (+) 
13 (S)-6a >99 85 (-) 
14 (S)-6b >99 96 (-) 
15 
 
(S)-6a >99 92 (R)25 
16 (R)-6b >99 90 (S) 
17 (R)-6c >99 94 (S) 
18 
 
(S)-6ac >99 92 (-) 
19 (R)-6bc >99 91 (+) 
20 (R)-6cc >99 95 (+) 
21 
 
(S)-4a >99 83 (-) 
22 (R)-5a >99 80 (+) 
23 (S)-6a >99 77 (+) 
24 (S)-6b >99 80 (+) 
25 
 
(S)-1ad >99 3 (R)26 
26 (S)-2ad >99 23 (S) 
27 (4S, 5S)-3ad >99 98 (R) 
28 (S)-4ad >99 87 (S) 
29 (R)-5ae >99 89 (R) 
30 (S)-6a >99 >99 (R) 
31 (S)-6b >99 >99 (R) 
32 
 
(S)-1a 40 69 (R) 
33 (S)-2a 88 86 (R) 
34 (S)-2ac >99 88 (R) 
35 (4S, 5S)-3a 75 25 (S) 
36 (S)-4a 42 67 (R) 
37 (R)-5a 8 63 (S) 
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38 (S)-6a 17 62 (S) 
39 (S)-6b 4 75 (S) 
a Determined by GC analysis of the reaction mixture after 
removal of the catalyst. b Determined by GC analysis on a 
chiral stationary phase. Absolute configurations are 
assigned based on sign of optical rotation reported in the 
cited references. c Reaction time: 4 h. d Reaction time: 6 h. 
e Reaction time: 24 h.  
The corresponding methyl-substituted vinylsilanes 
7c and 7d as well gave high enantioselectivities with 
pyridine-based ligands 6a-c (entries 15-20). The 
chloroalkyl-substituted vinylsilane 7e reacted with 
lower but still respectable enantioselectivity. In this 
case oxazoline- and imidazoline-based ligands 4a and 
5a also performed well, inducing ee values of 83% 
and 80%, respectively, comparable to pyridine-
phosphinites 6a and 6b (entries 21-24). 
Next, we studied the hydrogenation of silane (Z)-7f 
with a TMS group at the trisubstituted C atom, which 
leads to a product with a silyl-substituted stereogenic 
center. In contrast to Andersson's catalysts,10 which 
gave low enantioselectivity (28% ee) for this 
substrate, all of our phosphinite ligands 3a, 4a, 5a, 6a, 
and 6b performed well (entries 27-31). Especially 
pyridine-based ligands 6a and 6b stood out with 
enantioselectivities of >99% ee. Hydrogenation of the 
isomer (E)-7f proved to be more challenging (entries 
32-39). Most catalysts gave low conversion and only 
moderate to poor enantioselectivities (entries 33-34). 
Only the PyrPHOX complex [r(COD)(2a)]BArF 
produced the product with full conversion and an ee 
value of 88% after prolonged reaction time  of 4h. 
In further studies we focused on hydrogenation of 
vinylsilanes with terminal C=C bonds. As terminal 
olefins are known to react with higher 
enantioselectivity at lower pressure,30 catalyst 
screening was performed under 1 bar of hydrogen gas. 
First, we tested α−trimethylsilystyrene (7g) as 
substrate (Table 2). In all cases full conversion was 
obtained with enantioselectivities ranging from 13% 
to 88% ee. The best catalyst for this substrate was the 
complex derived from the pyridine-phosphinite 
ligand 6a (entry 6). Even better results were obtained 
with the corresponding cyclohexyl-substituted 
viylsilane 7h. Notably, besides the pyridine-
phosphinite 6a, the oxazoline- and imidazoline-based 
ligands 4a and 5a also performed well with this 
substrate (entries 11-13). Clearly the highest 
enantioselectivity (97% ee) was induced by ligand 4a. 
As observed before for vinylsilanes with 
trisubstituted C=C bonds (Table 1), replacement of a 
cyclohexyl substituent by a less sterically demanding 
n-alkyl group resulted in a loss of enantioselectivity 
(entries 15-17). SimplePHOX 4a was again the best 
performing ligand with an ee of 69%. 
The more sterically hindered dimethylphenylsilyl 
substituent in substrate 7j led to a strong decrease in 
reactivity compared to the TMS analog (entries 18-
21). Only 67% conversion was obtained under 
standard conditions with the catalyst derived from 
ligand 6a, although high levels of enantioselectivity 
were achieved. To speed up the reaction, the 
hydrogen pressure was raised to 5 bar. Under these 
conditions both the SimplePHOX (4a) and pyridine-
phosphinite (6a) complexes produced the product 
with full conversion and enantioselectivities of 81% 
and 91% ee, respectively, while the complex with the 
imidazoline-based ligand 5a showed poor reactivity 
and selectivity. 
 
Table 2 Asymmetric hydrogenation of terminal 
vinylsilanes. 
 
 
Entry Substrate L 
Conv. 
(%)a 
Ee (%)b 
1 
 
(S)-1a >99 30 (S)27 
2 (S)-2a >99 27(S) 
3 (4S, 5S)-3a >99 74 (S) 
4 (S)-4a >99 20 (R) 
5 (R)-5a >99 67(S) 
6 (S)-6a >99 88 (S) 
7 (S)-6b >99 13 (R) 
8 
 
(S)-1a 93 20 (+) 
9 (S)-2a >99 36 (+) 
10 (4S, 5S)-3a >99 48 (-) 
11 (S)-4a >99 97 (+) 
12 (R)-5a >99 88 (-) 
13 (S)-6a >99 90 (-) 
14 (S)-6b 40 47 (-) 
15 
 
(S)-4a >99 69 (R)28 
16 (R)-5a >99 65 (S) 
17 (S)-6a >99 46 (S) 
18 
 
(S)-4ac >99 81d (R)29 
19 (R)-5ac 51 50 (S) 
20 (S)-6a 68 91 (S) 
21 (S)-6ac >99 91 (S) 
a Determined by GC analysis of the reaction mixture after 
removal of the catalyst. b Determined by GC analysis on a 
chiral stationary phase. Absolute configurations are 
assigned based on sign of optical rotation reported in the 
cited references. c Under 5 bar of H2. 
d Determined by GC 
analysis after conversion to its corresponding alcohol. 
In view of the promising results obtained with 
trimethylsilyl- and dimethylphenysilyl-substituted 
alkenes, we decided to explore further silane 
derivatives. 
Trialkoxysilyl-substituted alkenes were chosen 
because the hydrogenation products can be readily 
transformed to enantioenriched alcohols3 or 
trifluorosilanes,31 the latter being of interest as 
starting compounds for stereoselective sp2-sp3 
Hiyama cross-coupling reactions.32 
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Initial hydrogenations of triethoxy(vinyl)silane 7k 
under standard conditions (0.5 mol % catalyst loading, 
50 bar H2) led to an inseparable mixture of the 
desired product 8k and a side product, to which we 
assigned structure 9 based on MS and NMR data 
(Table 3, entry 1). As this side product likely results 
from an acid-promoted33 condensation, 5 mol% of 
potassium carbonate was added to the reaction 
mixture. As hoped, the reaction proceeded smoothly 
to give the saturated triethoxysilane 8k as the sole 
product (entries 2-7). The best enantioselectivity 
(70% ee) was achieved with complexes derived from 
SimplePHOX ligand 4b and phosphino-imidazoline 
(PHIM)17 10a. 
Table 3 Asymmetric hydrogenation of 
trialkoxy(vinyl)silanes 
 
 
Entry Substrate L 
Conv. 
(%)a 
Ee 
(%)b 
1 
 
(S)-4bc 53 n.d.d 
2 (4S, 5S)-3a >99 64 (-) 
3 (S)-4a >99 44 (+) 
4 (S)-4b >99 70 (+) 
5 (S)-6a >99 20 (+) 
6 (R)-6b >99 16 (-) 
7 (S)-10a >99 70 (+) 
8 
 
(4S, 5S)-3a >99 77 (-) 
9 (4S, 5S)-3ae >99 80 (-) 
10 (S)-4b >99 51 (+) 
11 (S)-10a 90 65 (+) 
12 
 
(4S, 5S)-3a >99 44 (+) 
13 (S)-4b >99 88  (-) 
14 (S)-10b >99 79 (-) 
a Determined by GC analysis of the reaction mixture after 
removal of the catalyst. b Determined by GC or HPLC 
analysis on a chiral stationary phase. c In the absence of 
K2CO3, 16 h. 
d Not determined because of overlapping 
peaks of one enantiomer and the side product. e Under 5 
bar of H2. 
 
Fig. 2 ligands 10 and 11. 
 
The trimethoxysilyl substituted analogue 7l gave 
similar results (entries 8-11). However, a different 
ligand, the ThrePHOX derivative 3a, performed best 
in this case. As generally observed for terminal 
olefins, the enantioselectivity was higher at low 
hydrogen pressure, however, the difference was small 
(3a: 77% ee at 50 bar vs 80% ee at 5 bar; entries 8 
and 9). Consistent with the results obtained for the 
TMS analogues 7h and 7i (Table 2), better 
enantioselectivity (88% ee) was achieved with the 
cyclohexyl-substituted vinylsilane 7m compared to 
the corresponding n-alkyl-substituted substrate 7l. In 
this case, the optimal ligand was the SimplePHOX 
derivative 4b (entry 13). 
Due to ring strain, siletanes (silacyclobutanes) 
have unique properties that distinguish them from 
analogous acyclic alkylsilanes. They have been 
shown to readily undergo Tamao-Fleming oxidation 
and therefore can be used as hydroxyl surrogates.34 
Moreover, they can be converted to structurally 
diverse products by transition metal-catalyzed 
reactions involving insertion and ring expansion.35 
We therefore decided to study the asymmetric 
hydrogenation of vinylsiletanes as a possible 
approach to enantioenriched alkylisiletanes. 
 
 
Scheme 1 Asymmetric hydrogenation of vinylsiletanes. 
Initial experiments with siletane 7n were 
discouraging. With most catalysts complex, mixtures 
of the desired product 8n and several unidentified 
products were formed. Better results were finally 
obtained with PHOX complexes, especially with 
[Ir(COD)(1d)]BArF, which gave 93% conversion to 
the hydrogenation product 8n in 75% ee and only 
minor amounts of an unidentified byproduct (Scheme 
1). When the temperature was lowered to 0 °C, the ee 
increased to 83%. 
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Finally, we investigated the hydrogenation of 
functionalized vinylsilanes bearing a carboxylic ester 
or hydroxymethyl group at the C=C bond. 
 
PhMe2Si
CO2Et
7oa
(S)-1b, >99% conv., 26% ee (-)
(4S, 5S)-3b, 98%  conv., 42% ee (-)
(S)-4a, >99% conv., 68% ee (-)
(S)-6a, 32%  conv., 60% ee (+)
(R)-6b, 17% conv., 64% ee (-)
(S)-6d, 33% conv., 90% ee (+)
(S)-6d, >99%  conv., 89% ee (+)c
PhMe2Si OH
(S)-4a, 67% conv., 74% ee (+)
(S)-4b, 1% conv., n.d.
(R)-11a, >99% conv., 86% ee (-)
(R)-11b, 17% conv., 62% ee (-)
7pb
 
Figure 3 Asymmetric hydrogenation of α,β-unsaturated 
ester 7o and allylic alcohol 7p. a Reaction conditions: 0.5 
mol % catalyst loading, 50 bar H2, rt, 4 h in CH2Cl2. 
b 
Reaction conditions: 1.0 mol % catalyst loading, 50 bar H2, 
rt, 12 h in CH2Cl2.  
c 1.0 mol % catalyst loading, 12 h. 
The α,β-unsaturated ester 7o was first tested under 
standard conditions (0.5 mol % catalyst loading, 50 
bar H2, 4h). Most catalysts that we evaluated yielded 
the desired product 8o with full conversion, with the 
exception of Ir complexes derived from pyridine-
phosphinite ligands 6a-b and 6d, which were poorly 
active. However, the highest enantioselectivity (90% 
ee) was achieved with ligand 6d, which bears a 
sterically demanding aryl substituent at the pyridine 
ring (Figure 3). With higher catalyst loading (1 
mol%) and over a prolonged reaction time of 12 
hours, the reaction went to completion with 
essentially the same enantioselectivity (89% ee). 
Compared to the α,β-unsaturated ester 7o the 
allylic alcohol 7p was less reactive. Using 1.0 mol% 
of catalyst at 50 bar H2 at room temperature, most 
catalysts did not give any conversion after a reaction 
time of 12 h, except for complexes derived from 
SimplePHOX16 and NeoPHOX36 ligands. The 
substituents on the phosphorus atom seem to play a 
crucial role in these catalysts. Ligands 4a and 11a, 
both bearing a bis(ortho-tolyl)phosphine group, 
showed higher levels of activity and 
enantioselectivity than their analogues 4b and 11b. 
The best result (>99% conv., 86% ee) was achieved 
with the catalyst derived from NeoPHOX ligand 11a.  
In conclusion, in this study that included a variety 
of vinyl silanes with trisubstituted or disubstituted 
terminal C=C bonds and a diverse array of Ir N,P-
ligand complexes as catalysts, we have shown that 
asymmetric hydrogenation provides efficient access 
to wide range of chiral organosilanes with high 
enantioselectivity. Both substrates with or without 
coordinating groups at the C=C bond were 
successfully hydrogenated. Depending on the 
substrate structure, different ligand complexes 
emerged as the catalysts of choice. The best catalysts 
identified in our study significantly enhance the 
substrate scope in the asymmetric hydrogenation of 
silyl-substituted C=C bonds, opening up an attractive 
enantioselective route to chiral organosilanes. 
Experimental Section 
A 2 mL glass vial was charged with a cylindrical stirring 
bar (0.7 cm in length), the relevant iridium catalyst (0.5–
1.0 mol%) and the substrate (100 µmol). The mixture was 
dissolved in CH2Cl2 (0.5 mL, 0.2 M) and placed in an 
autoclave. The autoclave was attached to a high pressure 
hydrogen line and purged with H2 three times before being 
sealed under the appropriate H2 pressure. The mixture was 
stirred for the appropriate reaction time at rt. After release 
of H2, the solution was concentrated under a stream of 
nitrogen. The crude reaction mixture was then dissolved in 
0.5 mL of a 4:1 n-hexane:MTBE mixture and the catalyst 
removed by filtration through a plug of SiO2 in a Pasteur 
pipette. After washing with ca. 5 mL of a 4:1 n-
hexane:MTBE mixture, the solvent was concentrated in 
vacuo to yield the hydrogenation product. 
Analytical data and determination of enantioselectivities: 
see supporting information. 
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